Just like their best peers on either coast, mid-continent innovators can co-found successful scientific startups contribute to society’s greater good and create economic value, in addition to enhancing the resources of their labs and the opportunities for their colleagues.
C-suite executives who have successfully scaled startups can bring their talents to bear to increase human health and well being, by accessing extraordinary opportunities to build and create economic value – opportunities that may well be overlooked or not considered because of their mid-continent origin.
Philanthropists, charities and foundations can enhance the societal impact of their philanthropic investments in a research university – including cures for life-threatening diseases – while attracting additional investments from other donors. They, too, can identify and invest in preeminent innovators capable of solving societal problems that are a priority to them.
Downstream investors can rely on a source of high-quality, portfolio-ready investment opportunities that might otherwise be overlooked and cost-prohibitive because of their mid-continent origin.